Modulation of sterol biosynthesis regulates viral replication and cytokine production in influenza A virus infected human alveolar epithelial cells

• Published in: Antiviral research 2015-07, Vol.119, p.1-7
• Main Authors: Hui, Kenrie P.Y., Kuok, Denise I.T., Kang, Sara S.R., Li, Hung-Sing, Ng, Mandy M.T., Bui, Christine H.T., Peiris, J.S. Malik, Chan, Renee W.Y., Chan, Michael C.W.
• Format: Article
• Language: English
• Subjects: Antiviral Agents - pharmacology; Cells, Cultured; Cytokine; Cytokines - biosynthesis; Cytokines - immunology; Diphosphonates - pharmacology; Epithelial Cells - drug effects; Epithelial Cells - metabolism; Epithelial Cells - virology; Farnesyl transferase inhibitor; Humans; Imidazoles - pharmacology; Influenza A virus; Influenza A Virus, H1N1 Subtype - drug effects; Influenza A Virus, H1N1 Subtype - immunology; Influenza A Virus, H1N1 Subtype - metabolism; Influenza A Virus, H5N1 Subtype - drug effects; Influenza A Virus, H5N1 Subtype - immunology; Influenza A Virus, H5N1 Subtype - physiology; Leucine - analogs & derivatives; Leucine - pharmacology; Naphthalenes - pharmacology; Orthomyxoviridae; Pulmonary Alveoli - drug effects; Pulmonary Alveoli - metabolism; Pulmonary Alveoli - virology; Simvastatin - pharmacology; Statin; Sterol biosynthesis; Sterols - biosynthesis; Virus Replication - drug effects; Zometa
• ISSN: 0166-3542; 1872-9096
• DOI: 10.1016/j.antiviral.2015.04.005

•Simvastatin inhibited virus replication and cytokine production by H5N1 virus.•Zometa and FPT inhibitor III inhibited both H5N1 and H1N1 replication.•FPT inhibitor III is a strong immuno-regulator during H5N1 infection.•Protein farnesylation plays a role in cytokine induction by H5N1 virus. Highly pathogenic H5N1 viruses continue to transmit zoonotically, with mortality higher than 60%, and pose a pandemic threat. Antivirals remain the primary choice for treating H5N1 diseases and have their limitations. Encouraging findings highlight the beneficial effects of combined treatment of host targeting agents with immune-modulatory activities. This study evaluated the undefined roles of sterol metabolic pathway in viral replication and cytokine induction by H5N1 virus in human alveolar epithelial cells. The suppression of the sterol biosynthesis by Simvastatin in human alveolar epithelial cells led to reduction of virus replication and cytokine production by H5N1 virus. We further dissected the antiviral role of different regulators of the sterol metabolism, we showed that Zometa, FPT inhibitor III, but not GGTI-2133 had anti-viral activities against both H5N1 and H1N1 viruses. More importantly, FPT inhibitor III treatment significantly suppressed cytokine production by H5N1 virus infected alveolar epithelial cells. Since both viral replication itself and the effects of viral hyper-induction of cytokines contribute to the immunopathology of severe H5N1 disease, our findings highlights the therapeutic potential of FPT inhibitor III for severe human H5N1 diseases. Furthermore, our study is the first to dissect the roles of different steps in the sterol metabolic pathway in H5N1 virus replication and cytokine production.